Layer, Chiang, et al. Genome Biology
Qiagen Claims Market Leadership in HPV Testing as Molecular Dx Business Drives Q2 Revenue Growth
In a conference call to discuss its second-quarter earnings, the company told investors that it will delay the anticipated launch time of its higher throughput and fully automated QIAensemble Revolution platform for HPV and other molecular testing in an effort to make it more amenable to centralized testing labs.
New to GenomeWeb? Register here quickly.